Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/14850
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNunthanavanit P.
dc.contributor.authorAnthony N.G.
dc.contributor.authorJohnston B.F.
dc.contributor.authorMackay S.P.
dc.contributor.authorUngwitayatorn J.
dc.date.accessioned2021-04-05T04:31:58Z-
dc.date.available2021-04-05T04:31:58Z-
dc.date.issued2008
dc.identifier.issn3656233
dc.identifier.other2-s2.0-50949092681
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/14850-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-50949092681&doi=10.1002%2fardp.200700229&partnerID=40&md5=2a49c59d1f6f111004e25d0b3640205e
dc.description.abstractThree-dimensional quantitative structure-activity relationship (3D-QSAR) models were developed for chromone derivatives against HIV-1 protease using molecular field analysis (MFA) with genetic partial least square algorithms (G/PLS). Three different alignment methods: field fit, pharmacophore-based, and receptor-based were used to derive three MFA models. All models produced good predictive ability with high cross-validated r2 (r2 cv), conventional r2, and predictive r2 (r 2pred) values. The receptor-based MFA showed the best statistical results with r2cv = 0.789, r2 = 0.886, and r2pred = 0.995. The result obtained from the receptor-based model was compared with the docking simulation of the most active compound 21 in this chromone series to the binding pocket of HIV-1 protease (PDB entry 1AJX). It was shown that the MFA model related well with the binding structure of the complex and can provide guidelines to design more potent HIV-1 protease inhibitors. © 2008 Wiley-VCH Verlag GmbH & Co. KGaA.
dc.subjectchromone derivative
dc.subjectproteinase inhibitor
dc.subjectchromone derivative
dc.subjectp16 protease, Human immunodeficiency virus 1
dc.subjectproteinase
dc.subjectproteinase inhibitor
dc.subjectarticle
dc.subjectdrug protein binding
dc.subjectmolecular model
dc.subjectpharmacophore
dc.subjectpredictive validity
dc.subjectpriority journal
dc.subjectquantitative structure activity relation
dc.subjectsimulation
dc.subjectthree dimensional imaging
dc.subjectalgorithm
dc.subjectbinding site
dc.subjectchemical structure
dc.subjectchemistry
dc.subjectconformation
dc.subjectdrug design
dc.subjectregression analysis
dc.subjectAlgorithms
dc.subjectBinding Sites
dc.subjectChromones
dc.subjectDrug Design
dc.subjectHIV Protease
dc.subjectHIV Protease Inhibitors
dc.subjectLeast-Squares Analysis
dc.subjectModels, Molecular
dc.subjectMolecular Conformation
dc.subjectQuantitative Structure-Activity Relationship
dc.title3D-QSAR studies on chromone derivatives as HIV-1 protease inhibitors: Application of molecular field analysis
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationArchiv der Pharmazie. Vol 341, No.6 (2008), p.357-364
dc.identifier.doi10.1002/ardp.200700229
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.